Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56326 - 56350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	LINC00491	285708	upregulated	panobinostat results in increased expression of LINC00491 mRNA	5q21.1	A21037
Panobinostat	Approved Investigational	LINC00515	282566	downregulated	panobinostat results in decreased expression of LINC00515 mRNA	21q21.3	A21037
Panobinostat	Approved Investigational	LINC00540	100506622	upregulated	panobinostat results in increased expression of LINC00540 mRNA	13q12.11	A21037
Panobinostat	Approved Investigational	LINC00545	440132	upregulated	panobinostat results in increased expression of LINC00545 mRNA	13q12.3	A21037
Panobinostat	Approved Investigational	LINC00698	285401	upregulated	panobinostat results in increased expression of LINC00698 mRNA	3p14.2	A21037
Panobinostat	Approved Investigational	LINC01003	100128822	upregulated	panobinostat results in increased expression of LINC01003 mRNA	7q36.1	A21037
Panobinostat	Approved Investigational	LINC01405	100131138	upregulated	panobinostat results in increased expression of LINC01405 mRNA	12q24.11	A21037
Panobinostat	Approved Investigational	LINGO2	158038	upregulated	panobinostat results in increased expression of LINGO2 mRNA	9p21.2-p21.1	A21037
Panobinostat	Approved Investigational	LIX1	167410	downregulated	panobinostat results in decreased expression of LIX1 mRNA	5q15	A21037
Panobinostat	Approved Investigational	LMAN1	3998	downregulated	panobinostat results in decreased expression of LMAN1 mRNA	18q21.32	A21037
Panobinostat	Approved Investigational	LMF1	64788	upregulated	panobinostat results in increased expression of LMF1 mRNA	16p13.3	A21037
Panobinostat	Approved Investigational	LMO2	4005	downregulated	panobinostat results in decreased expression of LMO2 mRNA	11p13	A21037
Panobinostat	Approved Investigational	LMO3	55885	downregulated	panobinostat results in decreased expression of LMO3 mRNA	12p12.3	A21037
Panobinostat	Approved Investigational	LNX1	84708	upregulated	panobinostat results in increased expression of LNX1 mRNA	4q12	A21037
Panobinostat	Approved Investigational	LPAR6	10161	upregulated	panobinostat results in increased expression of LPAR6 mRNA	13q14.2	A21037
Panobinostat	Approved Investigational	LRIG1	26018	downregulated	panobinostat results in decreased expression of LRIG1 mRNA	3p14.1	A21037
Panobinostat	Approved Investigational	LRP12	29967	downregulated	panobinostat results in decreased expression of LRP12 mRNA	8q22.3	A21037
Panobinostat	Approved Investigational	LRP2	4036	downregulated	panobinostat results in decreased expression of LRP2 mRNA	2q31.1	A21037
Panobinostat	Approved Investigational	LRRC17	10234	upregulated	panobinostat results in increased expression of LRRC17 mRNA	7q22.1	A21037
Panobinostat	Approved Investigational	LRRC3B	116135	downregulated	panobinostat results in decreased expression of LRRC3B mRNA	3p24.1	A21037
Panobinostat	Approved Investigational	LRRC55	219527	downregulated	panobinostat results in decreased expression of LRRC55 mRNA	11q12.1	A21037
Panobinostat	Approved Investigational	LRRC8B	23507	downregulated	panobinostat results in decreased expression of LRRC8B mRNA	1p22.2	A21037
Panobinostat	Approved Investigational	LRRC8E	80131	upregulated	panobinostat results in increased expression of LRRC8E mRNA	19p13.2	A21037
Panobinostat	Approved Investigational	LRRN3	54674	upregulated	panobinostat results in increased expression of LRRN3 mRNA	7q31.1	A21037
Panobinostat	Approved Investigational	LY75	4065	upregulated	panobinostat results in increased expression of LY75 mRNA	2q24.2	A21037

Displaying entries 56326 - 56350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability